Strata Skin Sciences(SSKN)
$0.00-0.00 (-99.00%)
SSKN
Strata Skin Sciences financials statements
$0.00
At close:-0.00 (-99.00%)
Want to see SSKN full AI Analyst Report?
Strata Skin Sciences (SSKN) Ratios
245 Followers
Strata Skin Sciences Ratios
SSKN's free cash flow for Q4 2025 was $-551.00K. For the 2025 fiscal year, SSKN's free cash flow was decreased by $-312.00K and operating cash flow was $-239.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Mar 23 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.58 | 1.13 | 1.28 | 1.30 | 1.56 |
| Quick Ratio | 0.48 | 0.98 | 1.06 | 0.89 | 1.29 |
| Cash Ratio | 0.30 | 0.50 | 0.56 | 0.40 | 0.98 |
| Solvency Ratio | -0.06 | -0.15 | -0.17 | 0.00 | 0.07 |
| Operating Cash Flow Ratio | -0.10 | 0.01 | -0.04 | -0.08 | 0.12 |
| Short-Term Operating Cash Flow Coverage | -0.18 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -12.01M | $ -14.59M | $ -13.79M | $ -12.94M | $ -1.21M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.53 | 0.45 | 0.37 | 0.16 | 0.17 |
| Debt-to-Equity Ratio | 5.59 | 3.31 | 1.23 | 0.39 | 0.32 |
| Debt-to-Capital Ratio | 0.85 | 0.77 | 0.55 | 0.28 | 0.24 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.75 | 0.54 | 0.26 | 0.22 |
| Financial Leverage Ratio | 10.50 | 7.27 | 3.31 | 2.39 | 1.83 |
| Debt Service Coverage Ratio | 0.01 | -1.27 | -2.00 | 1.15 | 5.39 |
| Interest Coverage Ratio | -2.98 | -4.39 | -5.25 | -5.02 | -14.02 |
| Debt to Market Cap | 0.27 | 0.14 | 0.08 | 0.03 | 0.01 |
| Interest Debt Per Share | 0.39 | 0.49 | 0.49 | 0.27 | 0.25 |
| Net Debt to EBITDA | 47.21 | -3.23 | -2.62 | 2.67 | -2.64 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.25% | 56.85% | 55.34% | 60.20% | 66.22% |
| EBIT Margin | -13.98% | -24.28% | -27.83% | -12.61% | -7.87% |
| EBITDA Margin | 0.58% | -8.47% | -10.13% | 3.12% | 5.76% |
| Operating Profit Margin | -19.01% | -27.58% | -25.79% | -12.86% | -14.68% |
| Pretax Profit Margin | -20.36% | -30.56% | -32.74% | -15.17% | -8.91% |
| Net Profit Margin | -20.40% | -30.05% | -32.47% | -15.35% | -9.03% |
| Continuous Operations Profit Margin | -20.40% | -30.05% | -32.47% | -15.35% | -9.03% |
| Net Income Per EBT | 100.19% | 98.34% | 99.16% | 101.15% | 101.27% |
| EBT Per EBIT | 107.10% | 110.82% | 126.94% | 118.00% | 60.70% |
| Return on Assets (ROA) | -20.51% | -27.90% | -25.78% | -10.62% | -5.81% |
| Return on Equity (ROE) | -215.30% | -202.86% | -85.36% | -25.42% | -10.65% |
| Return on Capital Employed (ROCE) | -154.37% | -42.98% | -28.83% | -11.97% | -13.03% |
| Return on Invested Capital (ROIC) | -30.14% | -41.64% | -28.26% | -11.86% | -12.91% |
| Return on Tangible Assets | -24.35% | -35.83% | -38.43% | -21.28% | -9.77% |
| Earnings Yield | -10.68% | -9.10% | -5.64% | -2.02% | -0.54% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.45 | 6.39 | 7.51 | 8.09 | 8.73 |
| Payables Turnover | 4.65 | 5.95 | 4.46 | 4.20 | 3.59 |
| Inventory Turnover | 4.55 | 6.45 | 5.57 | 2.59 | 2.90 |
| Fixed Asset Turnover | 3.11 | 2.96 | 2.69 | 4.27 | 3.99 |
| Asset Turnover | 1.01 | 0.93 | 0.79 | 0.69 | 0.64 |
| Working Capital Turnover Ratio | -6.69 | 12.57 | 8.96 | 6.43 | 4.56 |
| Cash Conversion Cycle | 50.60 | 52.42 | 32.17 | 98.94 | 65.84 |
| Days of Sales Outstanding | 49.00 | 57.13 | 48.58 | 45.13 | 41.80 |
| Days of Inventory Outstanding | 80.15 | 56.61 | 65.49 | 140.67 | 125.75 |
| Days of Payables Outstanding | 78.55 | 61.32 | 81.91 | 86.86 | 101.71 |
| Operating Cycle | 129.15 | 113.74 | 114.07 | 185.80 | 167.55 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | 0.00 | -0.01 | -0.03 | 0.04 |
| Free Cash Flow Per Share | -0.09 | -0.04 | -0.16 | -0.13 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | -1.90 | 0.11 | -0.10 | -0.31 | 0.41 |
| Capital Expenditure Coverage Ratio | -1.90 | 0.11 | -0.10 | -0.31 | 0.41 |
| Operating Cash Flow Coverage Ratio | -0.17 | 0.01 | -0.03 | -0.13 | 0.19 |
| Operating Cash Flow to Sales Ratio | -0.09 | 0.01 | -0.02 | -0.03 | 0.05 |
| Free Cash Flow Yield | -7.27% | -1.31% | -2.88% | -1.70% | -0.43% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.93 | -11.19 | -17.73 | -49.42 | -184.34 |
| Price-to-Sales (P/S) Ratio | 1.91 | 3.30 | 5.76 | 7.58 | 16.64 |
| Price-to-Book (P/B) Ratio | 20.15 | 22.28 | 15.14 | 12.56 | 19.63 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -13.75 | -76.51 | -34.68 | -58.85 | -232.56 |
| Price-to-Operating Cash Flow Ratio | -20.97 | 589.30 | -370.06 | -247.50 | 330.79 |
| Price-to-Earnings Growth (PEG) Ratio | -0.00 | 0.69 | -0.19 | -0.49 | 4.75 |
| Enterprise Value Multiple | 378.27 | -42.21 | -59.44 | 245.77 | 286.04 |
| Enterprise Value | 66.95M | 119.97M | 200.91M | 277.23M | 494.28M |
| EV to EBITDA | 378.27 | -42.21 | -59.44 | 245.77 | 286.04 |
| EV to Sales | 2.18 | 3.57 | 6.02 | 7.67 | 16.49 |
| EV to Free Cash Flow | -15.71 | -82.85 | -36.28 | -59.49 | -230.43 |
| EV to Operating Cash Flow | -23.96 | 638.12 | -387.11 | -250.21 | 327.77 |
| Tangible Book Value Per Share | -0.04 | -0.08 | -0.03 | -0.13 | 0.19 |
| Shareholders’ Equity Per Share | 0.06 | 0.13 | 0.36 | 0.63 | 0.75 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | 0.02 | 0.01 | -0.01 | -0.01 |
| Revenue Per Share | 0.66 | 0.88 | 0.96 | 1.04 | 0.88 |
| Net Income Per Share | -0.13 | -0.26 | -0.31 | -0.16 | -0.08 |
| Tax Burden | 1.00 | 0.98 | 0.99 | 1.01 | 1.01 |
| Interest Burden | 1.46 | 1.26 | 1.18 | 1.20 | 1.13 |
| Research & Development to Revenue | 0.01 | 0.03 | 0.04 | 0.03 | 0.05 |
| SG&A to Revenue | 0.76 | 0.70 | 0.32 | 0.28 | 0.32 |
| Stock-Based Compensation to Revenue | 0.02 | 0.01 | 0.04 | 0.04 | 0.05 |
| Income Quality | 0.45 | -0.02 | 0.05 | 0.20 | -0.56 |
Currency in USD
